The new product from Animas, a division of Johnson and Johnson, is the first to incorporate the Dexcom G4 Platinum CGM technology, which will assist the management of people with insulin-requiring diabetes of 18 years and above.
The CGM technology samples interstitial fluid every 5 minutes, providing a trend of blood sugar levels and then allowing users to read data from the pump screen itself.
Users of the Animas Vibe can have basal insulin delivery pre-programmed, enabling precise insulin dosages to be delivered depending on blood glucose readings. A push of a button can pump in bolus insulin when appropriate.
The Animas Vibe insulin pump is waterproof for up to 12ft for 23 hours. The transmitter of the Dexcom CGM is also water resistant up to eight feet for 24 hours.
Other features of the Animas Vibe include customized dosing, which allows for up to 12 personalized settings of insulin-to-carbs ratio and insulin sensitivity, as well as customizable alarms to indicate high or low blood glucose levels.
Source: Animas Corp.
Latest from Today's Medical Developments
- Gore completes acquisition of Conformal Medical
- Medical textiles designed for cardiovascular, orthopedic, dental prosthetic applications
- Micro-precision 3D printing: Trends and breakthroughs in medical device manufacturing
- One-component, dual-cure adhesive system for medical device assembly
- #82 Manufacturing Matters - Forecasting 2026 with GIE Media's Manufacturing Group
- Flexing prosthetic finger offers lifelike appearance and movement
- How the fast-evolving defense market impacts suppliers
- Medtronic’s Hugo robotic-assisted surgery system makes US debut
